BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 33976691)

  • 21. Vitrectomy after intravitreal bevacizumab (Avastin) for retinal detachment in retinopathy of prematurity.
    Kychenthal A; Dorta P
    Retina; 2010 Apr; 30(4 Suppl):S32-6. PubMed ID: 20224474
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Retinal pigment epithelial tears after intravitreal bevacizumab injection for exudative age-related macular degeneration.
    Garg S; Brod R; Kim D; Lane RG; Maguire J; Fischer D
    Clin Exp Ophthalmol; 2008 Apr; 36(3):252-6. PubMed ID: 18412594
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Aggressive retinal astrocytoma associated with tuberous sclerosis.
    Tomida M; Mitamura Y; Katome T; Eguchi H; Naito T; Harada T
    Clin Ophthalmol; 2012; 6():715-20. PubMed ID: 22654497
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comparison of treatment response to intravitreal injection of triamcinolone, bevacizumab and combined form in patients with central retinal vein occlusion: A randomized clinical trial.
    Motarjemizadeh G; Rajabzadeh M; Aidenloo NS; Valizadeh R
    Electron Physician; 2017 Aug; 9(8):5068-5074. PubMed ID: 28979743
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The use of intravitreal anti-vascular endothelial growth factor injection and its complications in Chiang Mai University Hospital.
    Kunavisarut P; Saenpen N; Ittipunkul N; Patikulsila D; Choovuthayakorn J; Watanachai N; Pathanapitoon K
    J Med Assoc Thai; 2013 Nov; 96(11):1483-90. PubMed ID: 24428099
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Role of intravitreal bevacizumab in Eales disease with dense vitreous hemorrhage: a prospective randomized control study.
    Patwardhan SD; Azad R; Shah BM; Sharma Y
    Retina; 2011 May; 31(5):866-70. PubMed ID: 21301382
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Retinal detachment with macular hole following combined photodynamic therapy and intravitreal bevacizumab injection.
    Chung EJ; Koh HJ
    Korean J Ophthalmol; 2007 Sep; 21(3):185-7. PubMed ID: 17804928
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Comparison of the Safety and Efficacy of Intravitreal Ranibizumab with or without Laser Photocoagulation Versus Dexamethasone Intravitreal Implant with or without Laser Photocoagulation for Macular Edema Secondary to Branch Retinal Vein Occlusion.
    Kumar P; Sharma YR; Chandra P; Azad R; Meshram GG
    Folia Med (Plovdiv); 2019 Jun; 61(2):240-248. PubMed ID: 31301668
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Follow-up after surgery for hemorrhagic AMD.
    Garcia D; Mahieu L; Soubrane G; Salmon L; Renouvin A; Pagot-Mathis V; Matonti F; Soler V
    J Fr Ophtalmol; 2016 Oct; 39(8):661-667. PubMed ID: 27658564
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Intravitreal anti-vascular endothelial growth factor therapy with bevacizumab for tuberous sclerosis with macular oedema.
    Saito W; Kase S; Ohgami K; Mori S; Ohno S
    Acta Ophthalmol; 2010 May; 88(3):377-80. PubMed ID: 18778334
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Evaluation of intravitreal injection practice patterns in Cotonou].
    Agbahoungba L; Alamou S; Abouki C; Djossou-Doutetien A; Lawani R; Tchabi S
    J Fr Ophtalmol; 2018 Dec; 41(10):963-967. PubMed ID: 30470487
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Retinal pigment epithelial tears after intravitreal bevacizumab injection for neovascular age-related macular degeneration.
    Chan CK; Meyer CH; Gross JG; Abraham P; Nuthi AS; Kokame GT; Lin SG; Rauser ME; Kaiser PK
    Retina; 2007 Jun; 27(5):541-51. PubMed ID: 17558314
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Posterior subtenon and intravitreal triamcinolone acetonide for diabetic macular edema.
    Ozdek S; Bahçeci UA; Gürelik G; Hasanreisoğlu B
    J Diabetes Complications; 2006; 20(4):246-51. PubMed ID: 16798476
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Long-term results of the effect of intravitreal ranibizumab on the retinal arteriolar diameter in patients with neovascular age-related macular degeneration.
    Mendrinos E; Mangioris G; Papadopoulou DN; Donati G; Pournaras CJ
    Acta Ophthalmol; 2013 May; 91(3):e184-90. PubMed ID: 23590391
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Bevacizumab for the treatment of macular edema secondary to retinal vein occlusion].
    Schaal KB; Höh AE; Scheuerle A; Schütt F; Dithmar S
    Ophthalmologe; 2007 Apr; 104(4):285-9. PubMed ID: 17372737
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Intravitreal bevacizumab alone or combined with 1 mg triamcinolone in diabetic macular edema: a randomized clinical trial.
    Riazi-Esfahani M; Riazi-Esfahani H; Ahmadraji A; Karkhaneh R; Mahmoudi A; Roohipoor R; Ghasemi F; Yaseri M
    Int Ophthalmol; 2018 Apr; 38(2):585-598. PubMed ID: 28349504
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Intravitreal bevacizumab (Avastin) for neovascular age-related macular degeneration.
    Avery RL; Pieramici DJ; Rabena MD; Castellarin AA; Nasir MA; Giust MJ
    Ophthalmology; 2006 Mar; 113(3):363-372.e5. PubMed ID: 16458968
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Intravitreal versus retrobulbar injections of triamcinolone for macular edema associated with branch retinal vein occlusion.
    Hayashi K; Hayashi H
    Am J Ophthalmol; 2005 Jun; 139(6):972-82. PubMed ID: 15953425
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Complications of intravitreal steroid injections.
    Reichle ML
    Optometry; 2005 Aug; 76(8):450-60. PubMed ID: 16150412
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Intravitreal bevacizumab versus combined intravitreal bevacizumab and triamcinolone for neovascular age-related macular degeneration: six-month results of a randomized clinical trial.
    Ahmadieh H; Taei R; Riazi-Esfahani M; Piri N; Homayouni M; Daftarian N; Yaseri M
    Retina; 2011 Oct; 31(9):1819-26. PubMed ID: 21555967
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.